Imperative Care
Imperative Care accelerates the development of life-changing technologies for stroke and vascular diseases, offering interventional solutions and advancing innovative treatments through its Vascular business and subsidiaries like Kandu Health and Telos Health.
Company History
Imperative Care was established with the goal of accelerating the development of life-changing technologies for stroke and vascular diseases. Along the way, it has continuously sought to address gaps across the entire patient journey—from detection through recovery. Over time, Imperative Care has expanded its technological portfolio and partnerships, including the acquisition of Truvic Medical, Inc. The company has received significant funding, raising $260 million to further its innovative efforts in the field of stroke care.
Services
Imperative Care offers a comprehensive set of services centered around life-saving solutions for stroke and vascular diseases. The company's offerings address both ischemic and hemorrhagic strokes, as well as pulmonary embolism through its Vascular business. Kandu Health, a subsidiary of Imperative Care, provides tech-enabled healthcare services designed to aid stroke survivors and their care partners throughout the recovery process. Telos Health focuses on advancing technologies that enable physicians to perform thrombectomies on a global scale.
Products
Imperative Care's product portfolio includes several innovative technologies designed to improve stroke care. Some of their key products are the Zoom 88 Support, a device aimed at enhancing intracranial access for stroke patients, and the Zoom Stroke Solution, which aims for TICI 3 in just 10 minutes. Additional products include the TracStar LDP catheter, the Zoom POD filter, and a variety of Zoom Aspiration Catheters and the Zoom Pump. Each product is developed with the goal of providing efficient and effective solutions for physicians and patients alike.
Innovative Technologies
Imperative Care emphasizes rapid innovation in its core tenets, partnering closely with physicians to develop and validate new technologies. The company places significant importance on clinical data, utilizing large, prospective, multicenter trials along with smaller, single-center studies to substantiate their solutions. One of its hallmark innovations is the first-of-its-kind TracStar LDP catheter, which redefines intracranial access. The company also introduced the FDA-cleared Zoom 88 Support and the Zoom POD, the only filter designed to capture clot in the sterile field during stroke treatment.
Community Impact
Beyond its technological innovations, Imperative Care is dedicated to community education related to stroke and vascular disease awareness and prevention. The company's impact extends beyond clinical settings, focusing on educating the public on the importance of early detection and effective treatment options. With over 10,000 patients treated using their technologies, Imperative Care maintains a strong commitment to making a meaningful difference in the lives of individuals affected by stroke and vascular diseases.